Ready for the latest recommended weekly reads in the world of stem cells and the regenerative medicine space including a bunch of important new FDA posts & changes? This post has quite a lot on the FDA since it had a very big week with several new items of major importance to the cellular and regenerative […]
Weekly reads: FDA news, goosebump stem cells, MSCs, autophagy Read More »
Here are our weekly recommended regenerative medicine and other notable science reads including a few things on COVID. It’s been quite an interesting week. “Junk DNA” is not so junky, role in differentiation NIH scientists showed how ancient retroviral genes, or “junk DNA”, may play a role in helping stem cells decide to become neurons. This
Weekly reads: ‘junk DNA’, COVID chaos, CRISPR CasΦ, & postdoc opps, more Read More »
The biotech Mesoblast is starting an expanded access study of its stem cell product for kids with a severe offshoot of COVID-19. The cellular drug in this case is remestemcel-L (more below). While most children fare better than adults in dealing with COVID-19, the rare subset of kids with COVID-19 for this study have more severe
New Mesoblast “COVID kid” stem cell study Read More »
A few times a month I do a recommended reads kind of post on more than just stem cells, which people seem to appreciate as a condensed list of new science and medicine. Scientists might ask each other, “what’s in your to-read list?” rather than “what’s in your wallet?” Here are some of the things
Recommended reads: autism, cancer, & nucleosomes Read More »
The FDA dropped a lengthy, extremely critical warning letter on a supplier of unproven exosome product called EUCYT Laboratories. For broader context, exosome therapy has somehow burst onto the scene when there’s no good data yet in my view to back up its use in the clinic. The FDA is taking notice with letters already sent
Getting 30 F grades? FDA Strongly Warns Exosome Firm EUCYT Read More »
My weekly roundups of biomedical news tend to focus on stem cells, but I read more broadly so it’s not just stem cells but also CAR-T cells and a lot more this week. CAR-T cells as senolytics? A team led by Scott Lowe has a new intriguing paper in Nature on using CAR-T cells to
Weekly roundup: CAR-T cells, exosomes, trout cloning Read More »
It was fascinating to read a new JAMA piece by the FDA on unproven stem cell clinics and other regenerative medicine firms. Many of these guys are profiteering off of buzz about exciting, but mostly unproven technologies. While the JAMA opinion piece reiterates the agency’s commitment to evidence-based regenerative medicine, it also makes some other
Striking FDA Hahn & Marks JAMA pub on regenerative clinics Read More »
One of the most common questions that patients have asked me over the last decade is, “how much does stem cell therapy cost?” They actually seem most often to want to know more specifically how much the treatments should cost. To try to authoritatively answer this we need data from the present and past along
How much does stem cell therapy cost in 2022? Read More »
I find following both stem cell news and the stream of interesting publications to be kind of fun and thought-provoking. This past week or two has been very busy. Here is a news summary and list of notable pubs. Stem Cell News on Parkinson’s Disease There were a number of interesting developments on the Parkinson’s
Stem cell news & pubs: Parkinson’s, Freezing, COVID, & More Read More »
What is platelet-rich plasma or PRP injection cost and is it worth trying? The goal of today’s post is to fact-check PRP based on the scientific literature and educate readers including on PRP cost. What is in this article PRP is getting more popular | Is it worth it? | What exactly is PRP?
What is PRP injection cost, risks, & possible benefits Read More »